China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.193
-0.008 (-3.75%)
At close: Nov 22, 2024, 4:00 PM
0.192
-0.001 (-0.26%)
After-hours: Nov 22, 2024, 7:53 PM EST
China Pharma Holdings Employees
China Pharma Holdings had 231 employees as of December 31, 2023. The number of employees decreased by 3 or -1.28% compared to the previous year.
Employees
231
Change (1Y)
-3
Growth (1Y)
-1.28%
Revenue / Employee
$24,003
Profits / Employee
-$20,537
Market Cap
3.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Genetic Technologies | 55 |
NovaBay Pharmaceuticals | 26 |
Azitra | 10 |
Chromocell Therapeutics | 8 |
Artelo Biosciences | 6 |
Synaptogenix | 5 |
Aptorum Group | 3 |
Tharimmune | 3 |
CPHI News
- 3 months ago - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - PRNewsWire
- 9 months ago - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split - PRNewsWire
- 1 year ago - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device - PRNewsWire
- 1 year ago - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs - PRNewsWire
- 1 year ago - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project - PRNewsWire